Fluoroquinolone treatment of skin and skin structure infections
- PMID: 10553712
- DOI: 10.2165/00003495-199958002-00016
Fluoroquinolone treatment of skin and skin structure infections
Abstract
When the causative pathogens are susceptible, the fluoroquinolones have been demonstrated to be highly efficacious in the treatment of both mild uncomplicated skin and skin structure infections as well as the more severe complicated infections involving these tissues, including infections of the feet of diabetic patients. These broad spectrum agents, particularly the newer fluoroquinolones with enhanced activity against gram-positive bacteria, are ideal for treating the often polymicrobial complicated skin and skin structure infections. The wisdom of treating uncomplicated skin infections, which are primarily due to staphylococci and streptococci wherein more narrow spectrum beta-lactam antibiotics would suffice, is questionable.
Similar articles
-
The use of fluoroquinolones in the treatment of skin infections.Expert Opin Pharmacother. 2004 Feb;5(2):237-46. doi: 10.1517/14656566.5.2.237. Expert Opin Pharmacother. 2004. PMID: 14996621 Review.
-
Levofloxacin. Its use in infections of the respiratory tract, skin, soft tissues and urinary tract.Drugs. 1998 Sep;56(3):487-515. doi: 10.2165/00003495-199856030-00013. Drugs. 1998. PMID: 9777318 Review.
-
The role of fluoroquinolones in skin and skin structure infections.Am J Clin Dermatol. 2002;3(1):37-46. doi: 10.2165/00128071-200203010-00004. Am J Clin Dermatol. 2002. PMID: 11817967 Review.
-
Sparfloxacin versus ciprofloxacin for the treatment of community-acquired, complicated skin and skin-structure infections.Clin Ther. 1999 Apr;21(4):675-90. doi: 10.1016/S0149-2918(00)88319-8. Clin Ther. 1999. PMID: 10363733 Clinical Trial.
-
Newer treatment options for skin and soft tissue infections.Drugs. 2004;64(15):1621-42. doi: 10.2165/00003495-200464150-00002. Drugs. 2004. PMID: 15257625 Review.
Cited by
-
Clinafloxacin versus piperacillin-tazobactam in treatment of patients with severe skin and soft tissue infections.Antimicrob Agents Chemother. 2001 Feb;45(2):525-31. doi: 10.1128/AAC.45.2.525-531.2001. Antimicrob Agents Chemother. 2001. PMID: 11158750 Free PMC article. Clinical Trial.
-
The Role of Fluoroquinolones in the Treatment of Skin and Soft Tissue Infection.Curr Infect Dis Rep. 2002 Oct;4(5):426-432. doi: 10.1007/s11908-002-0010-6. Curr Infect Dis Rep. 2002. PMID: 12228030
-
Are Respiratory Quinolones Useful for the Treatment of Skin and Soft Tissue Infections?Curr Infect Dis Rep. 2003 Oct;5(5):389-390. doi: 10.1007/s11908-003-0018-6. Curr Infect Dis Rep. 2003. PMID: 13678568 No abstract available.
-
Staphylococcal skin infections in children: rational drug therapy recommendations.Paediatr Drugs. 2005;7(2):77-102. doi: 10.2165/00148581-200507020-00002. Paediatr Drugs. 2005. PMID: 15871629 Review.
-
Fluoroquinolones for Dermatologists: A Practical Guide to Clinical Use and Risk Management.Pharmaceuticals (Basel). 2025 May 26;18(6):800. doi: 10.3390/ph18060800. Pharmaceuticals (Basel). 2025. PMID: 40573197 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical